@mur_mur0103: @ulliu.l #плавание #пловчиха #популярное #рекомендации

mur_murchik
mur_murchik
Open In TikTok:
Region: SE
Tuesday 17 March 2026 18:31:06 GMT
2781725
207344
731
13326

Music

Download

Comments

michaelkalashniko0
MichaelKalashnikov :
записаться на плавание что-ли
2026-03-18 04:25:49
4683
user71298253284686
CVAGA :
2026-03-19 15:45:01
1241
user1445676153958
xRalers :
вы че гоните,красивые девушки😁
2026-03-18 18:30:08
777
user82639286
Богдан🇺🇦 :
да да.. чувства .. в рамка.. в створках...
2026-04-13 14:03:07
463
muffindiver3000
Muffindiver3000 :
is it grippy?
2026-04-09 10:26:39
70
alexander_384569
Johnny Sins :
Something is off here
2026-03-27 18:04:36
44
nothing2seeheredude
SP :
2026-04-09 18:14:58
77
warface1123
warface11214 :
Да да чувства
2026-04-11 07:24:34
13
mikomoto26
Mikołaj :
jak zostać trenerem 😂😂😂
2026-03-19 04:46:35
57
tvoi.povelitel3
Твой хозяин :
Норм тузы
2026-03-25 20:32:45
19
andinmaxjjdlm
Крипточикатило :
2026-03-18 21:57:28
17
cascada.77
cascada77 :
я теперь понял смысл фразы "не поворачивайся"
2026-03-18 08:51:28
326
vanehka16
🌴Ванечка 🌴 :
чото слишком долго идёт видео
2026-03-19 18:18:04
18
milnavz
Шершень🐝 :
Пора записываться в бассейн
2026-04-11 11:59:07
9
user9277750403478
ℋ𝑜𝓃𝑒𝓎ℬ𝓁𝑜𝓈𝓈𝑒𝓂 :
да видим мы видим
2026-03-25 09:24:50
46
astmat1k1
vanechia :
о пловчихи в реках ура
2026-03-18 19:15:56
12
kozeejrreme
████████████████ :
Как купальник называется??
2026-03-17 18:36:27
290
toples_001
Kerych :
зачем я бросил плавание
2026-03-24 13:34:05
14
grif1t.7.zero
Grif1t 7\ zero :
надо бы в плаванье записаться
2026-03-19 14:14:17
14
kondow_zero
mest :
сорян кд
2026-03-20 12:45:46
9
zeroone237
ZeRo :
Beautiful
2026-03-18 09:07:28
5
sebastianocrasci1
seby :
wow 😍
2026-03-20 14:40:44
5
user120021558
TM_kraken :
есть вариант познакомиться ?
2026-03-17 19:11:13
79
lilpodoshva
podoshva2006 :
красивые девушки
2026-03-18 06:28:59
7
To see more videos from user @mur_mur0103, please go to the Tikwm homepage.

Other Videos

GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune
GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune

About